聯合博姿

Alliance Boots aims to be in the vanguard of China consolidation

Stefano Pessina, executive chairman of Alliance Boots, is looking to China for his next big deal, nine months after completing the multibillion pound sale of a stake in the retailer and pharmaceutical wholesaler to Walgreens.

Just a few weeks after striking the deal with Walgreens, which could eventually see the US pharmacy chain acquire the whole of the group for £10bn, Alliance Boots bought a minority stake in Nanjing Pharmaceutical, China’s fifth largest pharmaceutical wholesaler by sales. Alliance Boots already owns 50 per cent of Guangzhou Pharmaceuticals, China’s sixth largest pharmaceutical wholesaler.

But Mr Pessina forecasts further consolidation in China, the world’s third biggest pharmaceutical market, and wants Alliance Boots to be at the forefront of this activity.

您已閱讀30%(786字),剩餘70%(1823字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×